The Lead Episode 108: LIVE from Heart Rhythm 2025 in San Diego, A Discussion of Left Bundle Branch Area Pacing Compared to Biventricular Pacing in Candidates for Cardiac Resynchronization Therapy (LVEF <50%): Results from International Collaborative LBBAP Study (I-CLAS)-The Lead Episode 108 Speaker Information

The Lead Episode 108 Speaker Information

Pdf Summary

The discussion from Heart Rhythm 2025 in San Diego focused on comparing left bundle branch area pacing (LBBAP) to biventricular pacing in patients with left ventricular ejection fraction (LVEF) of 50%, who are candidates for cardiac resynchronization therapy. This session highlighted the findings from the International Collaborative LBBAP Study (I-CLAS), with an emphasis on understanding the efficacy and potential benefits of LBBAP versus traditional methods. The discussion was hosted by Dr. Michael S. Lloyd from Emory University, with contributions from Dr. Prashant Bhave and Dr. Hakeem Ayinde.<br /><br />The I-CLAS, authored by a team including Juan Carlos Diaz, William H. Sauer, and others, is published in the Heart Rhythm Journal supplement. It examines international data and outcomes related to the effectiveness of these pacing methods in synchronizing the heartbeat in patients with specific heart failure characteristics.<br /><br />Key takeaways from the discussion may include the effectiveness, patient outcomes, and potential advantages of LBBAP compared to biventricular pacing. The session also involved insights from the contributors, recognizing the importance of such studies in guiding clinical practices and improving patient care.<br /><br />The contributors, Dr. Bhave (affiliated with Wake Forest School of Medicine) and Dr. Ayinde (with Cardiology Associates of Fredericksburg), along with Dr. Lloyd, shared their perspectives, possibly discussing the practical aspects of implementing these therapies in clinical settings.<br /><br />Disclosure statements included honoraria, speaking, and consulting engagements for the participants with companies such as Medtronic, Boston Scientific, Johnson and Johnson, and others involved in cardiac device manufacturing, ensuring transparency of potential conflicts of interest.<br /><br />Overall, this session underscored the ongoing exploration and comparison of advanced pacing techniques, seeking to enhance therapeutic strategies for heart failure patients.

Keywords

Heart Rhythm 2025

San Diego

left bundle branch area pacing

biventricular pacing

cardiac resynchronization therapy

International Collaborative LBBAP Study

left ventricular ejection fraction

Dr. Michael S. Lloyd

Heart Rhythm Journal

cardiac device manufacturing